Evidence map›Paper›PMID 30243412›Full record

ArticleJournal of substance abuse treatment2018

How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment.

Shannon Gwin Mitchell, Laura B Monico, Maxine Stitzer, Timothy Matheson, James L Sorensen, Daniel J Feaster, Robert P Schwartz, Lisa Metsch

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of substance abuse treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01612169 (NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01612169 nacompletednot on this map

NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users

TypeinterventionalSponsorColumbia UniversityRan2012 to 2015Enrolled801ConditionsHIV, AIDS, Substance Abuse, InpatientArmsPatient Navigation (PN) Group, Patient Navigator Plus Contingency Management (PN+CM) Group
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shannon Gwin MitchellFriends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA. Electronic address: smitchell@friendsresearch.org.
Laura B MonicoFriends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA.
Maxine StitzerBehavioral Pharmacology Research Unit, Hopkins Bayview Medical Center, 5510 Nathan Shock Drive, Baltimore, MD 21223, USA.
Timothy MathesonSan Francisco Department of Public Health, 25 Van Ness Avenue, Suite 500, San Francisco, CA 94102, USA.
James L SorensenZuckerberg San Francisco General Hospital and Trauma Center, 1001 Potrero Avenue, SFGH Building 20, Rm. 2117, San Francisco, CA 94110, USA.
Daniel J FeasterDepartment of Public Health Sciences, University of Miami Miller School of Medicine, USA.
Robert P SchwartzFriends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD 21201, USA.
Lisa MetschDepartment of Sociomedical Sciences, Mailman School of public Health, Columbia University, 722 West 168th St. 9th floor, New York, NY 10032, USA.

Funding

FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUPU10DA013034 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SCHWARTZ, ROBERT P, STITZER, MAXINE L · 1999 to 2015
$25.2M
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Clinical Trials Network: Mid-Atlantic Integrated Care Research CollaborativeUG1DA013034 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SCHWARTZ, ROBERT P, STITZER, MAXINE L · 2015 to 2019
$11.0M
NIDA NIH HHS U10 DA013034NIDA NIH HHS U10 DA013720NIDA NIH HHS UG1 DA013034NIDA NIH HHS UG1 DA013720NIDA NIH HHS UG1 DA015815
6 · The paper itself

Abstract

BACKGROUND AND

aimsWhile patient navigation has been shown to be an effective approach for linking persons to HIV care, and contingency management is effective at improving substance use-related outcomes, Project HOPE combined these two interventions in a novel way to engage HIV-positive patients with HIV and substance use treatment. The aims of this paper are to examine patient navigator views regarding how contingency management interacted with and affected their navigation process.

designSemi-structured qualitative interviews.

participants22 patient navigators from the original 10 Project HOPE study sites. MEASUREMENTS: Individual, semi-structured interviews lasting approximately 60 min addressed the patient navigator's professional background, descriptions of the participant population, substance use disorder versus HIV treatment entry and engagement issues, and the use of contingency management within the navigation service delivery protocol.

findingsPatient navigators believed that financial incentives helped motivate participant attendance at navigation sessions, particularly early in study involvement, which helped them to establish rapport and develop relationships with participants. Patient navigators often noted that financial incentives positively influenced targeted HIV health-related behaviors, such as attending medical appointments, which provided a rapid pay-off with an escalating sum. Contingency management was more complex when used by the patient navigators for substance use-related behaviors, particularly when incentives revolved around negative urine screening. Patient navigators noted that not all participants responded the same way to the contingency management and that the incentives were particularly helpful when participants were financially strained with limited resources or when internal motivation was lacking.

conclusionsOverall patient navigators found the inclusion of contingency management to be helpful and affective at influencing participant behaviors, particularly concerning navigation session attendance and HIV healthcare-related participation. However, issues and concerns surrounding the inclusion of contingency management for drug-related behaviors as delivered in Project HOPE were noted. CLINICAL TRIALS REGISTRATION: NCT01612169.

Indexed as

Behavior TherapyFemaleHIV InfectionsHumansInterviews as TopicMaleMotivationPatient NavigationRewardSubstance-Related DisordersContingency managementHIV treatment entryPatient navigationQualitativeSubstance use

Identifiers

PMID30243412
PMCPMC6404543

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.